Open AccessJournal Article
Prevalence and clinical characteristics of dactylitis in spondylarthritis: a descriptive analysis of 275 patients.
Judith Payet,Laure Gossec,Simon Paternotte,Burki,Anne Durnez,Muriel Elhai,Isabelle Fabreguet,Eugénie Koumakis,Magali Meyer,Roure F,Maxime Dougados +10 more
TLDR
Dactylitis is a frequent manifestation in SpA particularly in peripheral disease and it may be the first manifestation of the disease with localisation being more frequent in the toes.Abstract:
OBJECTIVES Dactylitis is a common but little studied feature of spondylarthritis (SpA). Our objective was to assess the prevalence of dactylitis among a cohort of patients with spondylarthritis in a tertiary care centre and to describe the clinical characteristics of dactylitis. METHODS This was a prospective single centre observational study carried out in 2010. The patients included had been diagnosed as having definite SpA based on Amo's criteria. Each patient was interviewed by a physician. The data collected included prevalence of dactylitis and its clinical characteristics, effectiveness of the different treatments, and association with severe manifestations of SpA, and analysed by descriptive analysis. RESULTS 275 consecutive SpA patients were assessed: mean age 43.2±13.5 years, mean disease duration 14.0±11.8 years, 169 (61.4%) were men. In all, 59 patients (21.5%) suffered from SpA-associated dactylitis. The localisation of dactylitis was toes in 46 patients (78.0%) and/or fingers in 25 patients (42.4%). The most frequent localisations were the second toe and the second finger. Dactylitis was the first symptom of SpA in 14 patients (5.1%), and 28.8% (n=17) of dactylitis appeared within the first 5 years of disease. Dactylitis was present in 35.1% (n=13) of patients with undifferenciated SpA and in 30.6% (n=15) of patients with psoriatic arthritis. It was significantly associated with history of peripheral arthritis or heel pain. In our population, there was no correlation between dactylitis and HLA B27 status or sex and it was not a marker of severity of disease. CONCLUSIONS Dactylitis is a frequent manifestation in SpA (21.5%) particularly in peripheral disease and it may be the first manifestation of the disease with localisation being more frequent in the toes.read more
Citations
More filters
Journal ArticleDOI
The Epidemiology of Psoriatic Arthritis.
Alexis Ogdie,Pamela F. Weiss +1 more
TL;DR: In this review, current knowledge is discussed regarding the epidemiology of PsA, including disease manifestations, classification criteria for adult and juvenilePsA, methods for recognizing early PsA; use of screening tools and knowledge of risk factors for PsA%; and medical comorbidities associated with PsA.
Journal ArticleDOI
Enthesitis in psoriatic arthritis.
TL;DR: Enthesitis and dactylitis are important manifestations of PsA, and their evaluation is increasingly used in drug trials and clinical practice.
Journal ArticleDOI
Classification and Diagnosis of Axial Spondyloarthritis — What Is the Clinically Relevant Difference?
TL;DR: A analysis of differences between classification and diagnostic criteria for axial spondyloarthritis by discussing each feature of the classification criteria based on real cases is hoped to increase the understanding of diagnosing axSpA in relation to the ASAS classification criteria.
Journal ArticleDOI
Epidemiological analysis of psoriatic arthritis patients in Japan.
Toshiyuki Yamamoto,Mamitaro Ohtsuki,Shigetoshi Sano,Atsuyuki Igarashi,Akimichi Morita,Ryuhei Okuyama,Akira Kawada +6 more
TL;DR: The ratio of psoriatic arthritis in Japan is increasing, and nearly 10% of new psoriasis patients had psoriatics arthritis, including several unexpected findings such as male predominance, longer duration between the onset of cutaneous Psoriasis and arthritis, and dominance of polyarthritis.
Journal ArticleDOI
Langfassung zur S3-Leitlinie Axiale Spondyloarthritis inklusive Morbus Bechterew und Frühformen, Update 2019
Uta Kiltz,Jürgen Braun,A. Becker,Jean-François Chenot,M. Dreimann,L. Hammel,Arnd Heiligenhaus,K. G. Hermann,R. Klett,Dietmar Krause,K.‑F. Kreitner,Uwe Lange,A. Lauterbach,Wilfried Mau,R. Mössner,Oberschelp U,S. Philipp,Uwe Pleyer,M. Rudwaleit,Schneider E,T. L. Schulte,J. Sieper,Stallmach A,Swoboda B,Winking M +24 more
References
More filters
Journal ArticleDOI
Evaluation of diagnostic criteria for ankylosing spondylitis. A proposal for modification of the New York criteria.
TL;DR: The study showed the clinical history screening test for AS to be moderately sensitive, but it might be better in clinical practice, and substitution of the Rome pain criterion for the New York pain criterion is proposed.
Journal ArticleDOI
Classification criteria for psoriatic arthritis: Development of new criteria from a large international study
William J. Taylor,Dafna D. Gladman,Philip S. Helliwell,Antonio Marchesoni,Philip J. Mease,Herman Mielants +5 more
TL;DR: The CASPAR criteria are simple and highly specific but less sensitive than the Vasey and Espinoza criteria and are confirmed as the validity of clinical diagnosis as the gold standard definition of "case"-ness.
Journal ArticleDOI
The development of Assessment of SpondyloArthritis international Society classification criteria for axial spondyloarthritis (part II): validation and final selection
Martin Rudwaleit,D. van der Heijde,Robert Landewé,Joachim Listing,Nurullah Akkoc,J Brandt,Jürgen Braun,C.T. Chou,Eduardo Collantes-Estevez,Maxime Dougados,Feng Huang,Jieruo Gu,Muhammad Asim Khan,Yesim Kirazli,Walter P. Maksymowych,Herman Mielants,Inge Juul Sørensen,Salih Ozgocmen,Euthalia Roussou,R. Valle-Oñate,Ulrich Weber,James Cheng-Chung Wei,Joachim Sieper +22 more
TL;DR: The new ASAS classification criteria for axial SpA can reliably classify patients for clinical studies and may help rheumatologists in clinical practice in diagnosing axial spondyloarthritis in those with chronic back pain.
Journal ArticleDOI
Adalimumab for the treatment of patients with moderately to severely active psoriatic arthritis: Results of a double‐blind, randomized, placebo‐controlled trial
Philip J. Mease,Dafna D. Gladman,Christopher T. Ritchlin,Eric Ruderman,Serge Steinfeld,Ernest Choy,John T. Sharp,Peter A. Ory,Renee J. Perdok,M A Weinberg +9 more
TL;DR: Adalimumab significantly improved joint and skin manifestations, inhibited structural changes on radiographs, lessened disability due to joint damage, and improved quality of life in patients with moderately to severely active PsA.
Journal ArticleDOI
Infliximab improves signs and symptoms of psoriatic arthritis: results of the IMPACT 2 trial
C Antoni,Gerald G. Krueger,K. de Vlam,C. Birbara,A. Beutler,Cynthia Guzzo,B. Zhou,Lisa T. Dooley,Arthur Kavanaugh +8 more
TL;DR: Infliximab 5 mg/kg through 24 weeks significantly improved active PsA, including dactylitis and enthesopathy, and associated psoriasis.
Related Papers (5)
The Assessment of SpondyloArthritis international Society classification criteria for peripheral spondyloarthritis and for spondyloarthritis in general
The development of Assessment of SpondyloArthritis international Society classification criteria for axial spondyloarthritis (part II): validation and final selection
Martin Rudwaleit,D. van der Heijde,Robert Landewé,Joachim Listing,Nurullah Akkoc,J Brandt,Jürgen Braun,C.T. Chou,Eduardo Collantes-Estevez,Maxime Dougados,Feng Huang,Jieruo Gu,Muhammad Asim Khan,Yesim Kirazli,Walter P. Maksymowych,Herman Mielants,Inge Juul Sørensen,Salih Ozgocmen,Euthalia Roussou,R. Valle-Oñate,Ulrich Weber,James Cheng-Chung Wei,Joachim Sieper +22 more